Abstract
Of the tropical diseases, trypanosomiases and leishmaniases should most concern the pharmaceutical community because of their high prevalence in developing countries and the lack of effective drug treatments. Despite this, they have not historically received much attention in terms of investment and research effort, nor do they now. In very recent years, thanks to the involvement of several nonprofit organizations, the chemotherapeutic options have expanded with the introduction of the first combination therapy. The optimal efficacy and safety of nifurtimox – eflornithine combination against second-stage human African trypanosomiasis is an encouraging first step towards simpler and more affordable therapies. Along the same line, I propose that single chemical entities able to modulate more than one target may prove more efficacious and tolerable than the available arsenal of drugs. Herein, I discuss the pros and cons of this approach, together with examples taken from the recent literature.
Keywords: Neglected tropical diseases, combination therapy, multitarget drug discovery, hybrid compounds, leishmaniasis, trypanosomiasis, multitarget ligands, Nifurtimox benznidazole, toxic organic compound, mucocutaneous disease, chronic human trypanosomiasis, therapeutic compounds, antiretroviral treatment, visceralleishmaniases, axenic amastigote
Current Topics in Medicinal Chemistry
Title: Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
Volume: 11 Issue: 22
Author(s): Maria Laura Bolognesi
Affiliation:
Keywords: Neglected tropical diseases, combination therapy, multitarget drug discovery, hybrid compounds, leishmaniasis, trypanosomiasis, multitarget ligands, Nifurtimox benznidazole, toxic organic compound, mucocutaneous disease, chronic human trypanosomiasis, therapeutic compounds, antiretroviral treatment, visceralleishmaniases, axenic amastigote
Abstract: Of the tropical diseases, trypanosomiases and leishmaniases should most concern the pharmaceutical community because of their high prevalence in developing countries and the lack of effective drug treatments. Despite this, they have not historically received much attention in terms of investment and research effort, nor do they now. In very recent years, thanks to the involvement of several nonprofit organizations, the chemotherapeutic options have expanded with the introduction of the first combination therapy. The optimal efficacy and safety of nifurtimox – eflornithine combination against second-stage human African trypanosomiasis is an encouraging first step towards simpler and more affordable therapies. Along the same line, I propose that single chemical entities able to modulate more than one target may prove more efficacious and tolerable than the available arsenal of drugs. Herein, I discuss the pros and cons of this approach, together with examples taken from the recent literature.
Export Options
About this article
Cite this article as:
Laura Bolognesi Maria, Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases, Current Topics in Medicinal Chemistry 2011; 11 (22) . https://dx.doi.org/10.2174/156802611798184391
DOI https://dx.doi.org/10.2174/156802611798184391 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Single Chemical Entity Legal Highs: Assessing the Risk for Long Term Harm
Current Drug Abuse Reviews Biomarkers of Aging with Prognostic and Predictive Value in Non-Oncological Diseases
Current Medicinal Chemistry Chemical Connexin Impairment in the Developing Gonad Associated with Offspring Infertility
Current Medicinal Chemistry The Role of Hyperhomocysteinemia in the Development of Changes in the Lungs
Reviews on Recent Clinical Trials The Role of Essential Oils and the Biological Detoxification in the Prevention of Aflatoxin Borne Diseases
Current Topics in Medicinal Chemistry Depression and Anxiety During Pregnancy: Clinical Aspects
Current Psychiatry Reviews Muscarinic Acetylcholine Receptors
Current Pharmaceutical Design Annual Trends in Use of Periconceptional Folic Acid and Birth Prevalence of Major Congenital Malformations
Current Drug Safety Heart Failure in East Asia
Current Cardiology Reviews Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Expression and Functions of Vasoactive Substances Regulated by Hypoxia-Inducible Factor-1 in Chronic Hypoxemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Adrenomedullin and Oxidative Stress in Vascular Damage and Metabolic Disease
Current Hypertension Reviews Macrocyclic Histone Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Novel Drugs for Inflammatory Lung Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
Current Pharmaceutical Biotechnology QT Interval Monitoring and Drugs Management During COVID-19 Pandemic
Current Reviews in Clinical and Experimental Pharmacology New Vectors and Strategies for Cardiovascular Gene Therapy
Current Gene Therapy Targeting Cytokines: Production and Characterization of Anti-TNF-α scFvs by Phage Display Technology
Current Pharmaceutical Design